[Skip to Content]

Upstate Active Clinical Trials

Study Title:

ATRI-002: Long-Term Nicotine Treatment of Mild Cognitive Impairment (NIC study)

What is the purpose of the study?

To see if nicotine can improve symptoms of memory loss in people experiencing mild memory problems (mild cognitive impairment or MCI)

Upstate Institutional Review Board (IRB) Number:

1483191

Study/Protocol ID:

ATRI-002

Study Phase:

Phase 2

Patient Age Group:

Adults

Principal Investigator:

Sharon A Brangman

What is involved if I participate?

  • How long is the study?
    2 years
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Cognitive functioning testing

Where will the study take place?

Clinical Research Unit

ClinicalTrials.Gov ID:

NCT02720445

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Colleen A Dillenbeck
Phone: 315-464-9014
Email: dillenco@upstate.edu

Return to Previous Page || Search Again

Top